Adage Capital Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-186,200
Closed -$3.23M 910
2023
Q3
$3.23M Hold
186,200
0.01% 708
2023
Q2
$3.87M Sell
186,200
-16,400
-8% -$356K 0.01% 695
2023
Q1
$4.77M Buy
202,600
+7,762
+4% +$208K 0.01% 712
2022
Q4
$5.44M Buy
+194,838
New +$4.98M 0.01% 735
2022
Q3
Sell
-255,100
Closed -$8.61M 1096
2022
Q2
$8.61M Sell
255,100
-6,000
-2% -$210K 0.02% 704
2022
Q1
$9.12M Buy
+261,100
New +$8.93M 0.02% 717
2021
Q4
Sell
-259,680
Closed -$8.52M 1079
2021
Q3
$8.52M Buy
259,680
+99,150
+62% +$3.17M 0.02% 741
2021
Q2
$4.86M Buy
+160,530
New +$5.28M 0.01% 829

Other funds holding OGN

Adage Capital Partners's OGN Position: Q4 2023 in Review

Adage Capital Partners sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 186,200 shares — an estimated $3.23M sold.

Adage Capital Partners first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $9.12M in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Adage Capital Partners reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Adage Capital Partners sold 186,200 Organon & Co shares in Q4 2023, an estimated $3.23M.
  • Adage Capital Partners first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Adage Capital Partners's Organon & Co position peaked at $9.12M in Q1 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.